デフォルト表紙
市場調査レポート
商品コード
1529794

避妊の市場規模、シェア、動向分析レポート:製品別、地域別、セグメント予測、2024年~2030年

Contraceptive Market Size, Share, & Trends Analysis Report By Product (Contraceptive Devices, Contraceptive Drugs), By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.40円
避妊の市場規模、シェア、動向分析レポート:製品別、地域別、セグメント予測、2024年~2030年
出版日: 2024年07月18日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

避妊市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の避妊の市場規模は2030年までに440億4,000万米ドルに達すると予測され、予測期間中のCAGRは5.92%で成長すると予測されています。

性感染症(STI)、特にHIVの有病率の高まりと、発展途上国における避妊意識の高まりが、予測期間中の業界成長を促進すると予想されます。高いアンメット・避妊ニーズが存在し、有利な政府政策の実施と相まって、市場成長に大きく寄与すると予想されます。

避妊に対する政府支出は急速に増加しています。これは予測期間中の市場成長を促進すると予想されます。このような投資は通常、避妊サービスの助成や無料化、教育キャンペーン、配布プログラムなどの取り組みを支援しています。このような取り組みは、避妊具へのアクセシビリティを高め、家族計画やリプロダクティブ・ヘルスに関する意識を向上させ、市場の成長を後押しします。家族計画2030」報告書によると、2022年の家族計画への資金提供は米国が最も多く、約5億8,290万米ドル(43%)、次いでオランダ(2億1,740万米ドル(16%))、英国(1億7,470万米ドル(13%))、スウェーデン(1億2,130万米ドル(9%))、カナダ(8,830万米ドル(7%))となっています。

市場の競争が激しいため、大手企業は研究開発(R&D)への多額の投資に注力し、M&Aや製品パイプラインの拡充などさまざまな戦略を採用しています。例えば、2023年12月、ノッティンガムに本社を置く医薬品開発企業Quotient Sciences社は、YCT-529と呼ばれるホルモンフリーの男性用避妊薬の最初の臨床試験の開始を発表しました。

避妊市場レポートのハイライト

  • 製品別では、避妊器具分野が2023年に最大の売上高シェアで市場を独占しました。これは、避妊成功率が高いこと、避妊器具が単回使用であることに起因しています。
  • さらに、避妊薬セグメントは、入手のしやすさ、手頃な価格、これらの薬に関連する大きな成功率により、予測期間中に最も速いCAGRを示すことが期待されています。
  • 北米地域は2023年に最大の市場シェアを占めました。これは、ユーザーの意識レベルが高く、製品の入手が容易であることに起因しています。
  • 2023年6月、DKTヘルスケア・ウガンダは、性的パフォーマンスを長持ちさせ、カップルの親密な体験を高めるために設計された新しいコンドーム「キス・エクストラ・タイム」を発売しました。このコンドームは、Kiss Passion Fruit、Kiss Strawberry、Kiss Classic、Kiss Chocolate、Kiss Studdedなど、多様な嗜好に対応するようデザインされた他のバリエーションとともに、ウガンダ全土のドラッグストアや薬局で0.16米ドルで購入できます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場の課題分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 製品別ビジネス分析

  • 製品別市場シェア、2023年および2030年
  • 製品別セグメントダッシュボード
  • 市場規模と予測および動向分析、製品別、2018~2030年
  • 避妊薬
    • 避妊薬市場、2018年-2030年
    • 避妊薬
    • パッチ
    • 注射剤
  • 避妊具
    • 避妊具市場、2018年-2030年
    • コンドーム
    • 皮下インプラント
    • 子宮内避妊器具(IUD)
    • 膣リング
    • ダイヤフラム

第5章 用途・所有別の地域別推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年:
  • 北米
    • 北米の避妊市場推計・予測、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の避妊市場推計・予測、2018年-2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋地域の避妊市場推計・予測、2018年-2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの避妊市場推計・予測、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ避妊市場推計・予測、2018-2030
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 参入企業概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • AbbVie Inc.
    • Bayer AG
    • Organon Group of Companies
    • Pfizer Inc.
    • Afaxys, Inc.
    • Viatris Inc.
    • Agile Therapeutics
    • Johnson &Johnson Services, Inc.
    • HELM AG
    • Church &Dwight Co., Inc.
    • Veru Inc.
    • China Resources(Group)Co., LTD.
図表

List of Tables

  • Table 1 Global contraceptive market, by region estimates and forecast, 2018 - 2030 (USD Million)
  • Table 2 Global contraceptive market, by product estimates and forecast, 2018 - 2030 (USD Million)
  • Table 3 Global Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 6 Global Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 7 North America contraceptive market revenue estimates and forecast by country, 2018 - 2030 (USD Million)
  • Table 8 North America contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 9 North America Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 North America Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 U.S. Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 U.S. Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 19 Canada Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Canada Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Canada Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Canada Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 Mexico contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 24 Mexico Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 25 Mexico Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 Mexico Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Mexico Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 Europe contraceptive market revenue estimates and forecast by country, 2018 - 2030 (USD Million)
  • Table 29 Europe contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 30 Europe Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 Europe Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Europe Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Europe Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 UK contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 35 UK Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 UK Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 37 UK Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 UK Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Germany contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 40 Germany Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Germany Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Germany Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Germany Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 44 France contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 45 France Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 46 France Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 France Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 France Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 49 Italy contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 50 Italy Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Italy Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Italy Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 Italy Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 54 Spain contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 55 Spain Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Spain Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Spain Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 Spain Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Sweden contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 60 Sweden Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Sweden Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Sweden Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Sweden Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Norway contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 65 Norway Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 66 Norway Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Norway Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Norway Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 69 Denmark contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 70 Denmark Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Denmark Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Denmark Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Denmark Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific contraceptive market revenue estimates and forecast by country, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Japan contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 81 Japan Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 82 Japan Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Japan Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 Japan Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 China contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 86 China Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 China Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 China Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 China Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 90 India contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 91 India Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 India Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 India Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 India Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 95 Australia contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 96 Australia Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Australia Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Australia Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 99 Australia Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 100 South Korea contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 101 South Korea Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 South Korea Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 103 South Korea Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 104 South Korea Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 105 Thailand contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 106 Thailand Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 Thailand Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 108 Thailand Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 109 Thailand Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 110 Latin America contraceptive market revenue estimates and forecast by country, 2018 - 2030 (USD Million)
  • Table 111 Latin America contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 112 Latin America Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 113 Latin America Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Latin America Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 115 Latin America Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 116 Brazil contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 117 Brazil Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 Brazil Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 Brazil Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 120 Brazil Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 121 Mexico contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 122 Mexico Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 123 Mexico Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 124 Mexico Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 125 Mexico Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 126 Argentina contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 127 Argentina Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 128 Argentina Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 129 Argentina Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 130 Argentina Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa (MEA) contraceptive market revenue estimates and forecast by country, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa (MEA) contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa (MEA) Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 134 Middle East & Africa (MEA) Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 135 Middle East & Africa (MEA) Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 136 Middle East & Africa (MEA) Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 137 South Africa contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 138 South Africa Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 139 South Africa Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 140 South Africa Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 141 South Africa Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 142 UAE contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 143 UAE Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 144 UAE Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 145 UAE Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 146 UAE Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 147 Saudi Arabia contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 148 Saudi Arabia Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 149 Saudi Arabia Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 150 Saudi Arabia Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 151 Saudi Arabia Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait contraceptive market revenue estimates and forecast by product, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Contraceptive Drugs Market, by Product, 2018 - 2030 (USD Million)
  • Table 154 Kuwait Contraceptive Devices Market, by Product, 2018 - 2030 (USD Million)
  • Table 155 Kuwait Condom Market, by Type, 2018 - 2030 (USD Million)
  • Table 156 Kuwait Intrauterine Devices (IUDs) Market, by Type, 2018 - 2030 (USD Million)
  • Table 157 List of secondary sources
  • Table 158 List of abbreviation

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Contraceptive market: Product outlook and key takeaways
  • Fig. 17 Contraceptive market: Product movement analysis
  • Fig. 18 Contraceptive drugs market, 2018 - 2030 (USD Million)
  • Fig. 19 Contraceptive pills market, 2018 - 2030 (USD Million)
  • Fig. 20 Patch market, 2018 - 2030 (USD Million)
  • Fig. 21 Injectables market, 2018 - 2030 (USD Million)
  • Fig. 22 Contraceptive devices market, 2018 - 2030 (USD Million)
  • Fig. 23 Condom market, 2018 - 2030 (USD Million)
  • Fig. 24 Male condom market, 2018 - 2030 (USD Million)
  • Fig. 25 Female condom market, 2018 - 2030 (USD Million)
  • Fig. 26 Subdermal implants market, 2018 - 2030 (USD Million)
  • Fig. 27 IUDs market, 2018 - 2030 (USD Million)
  • Fig. 28 Copper IUDs market, 2018 - 2030 (USD Million)
  • Fig. 29 Hormonal IUDs market, 2018 - 2030 (USD Million)
  • Fig. 30 Vaginal ring market, 2018 - 2030 (USD Million)
  • Fig. 31 Diaphragm market, 2018 - 2030 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional outlook, 2023 & 2030
  • Fig. 34 Contraceptive market: Region movement analysis
  • Fig. 35 North America contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S.: Key Country Dynamics
  • Fig. 38 Canada contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada: Key Country Dynamics
  • Fig. 40 Mexico contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico: Key Country Dynamics
  • Fig. 42 Europe contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany: Key Country Dynamics
  • Fig. 45 UK contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 46 UK: Key Country Dynamics
  • Fig. 47 France contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 48 France: Key Country Dynamics
  • Fig. 49 Italy contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy: Key Country Dynamics
  • Fig. 51 Spain contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 52 Spain: Key Country Dynamics
  • Fig. 53 Sweden contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden: Key Country Dynamics
  • Fig. 55 Norway contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway: Key Country Dynamics
  • Fig. 57 Denmark contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark: Key Country Dynamics
  • Fig. 59 Asia Pacific contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 61 Japan: Key Country Dynamics
  • Fig. 62 China contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 63 China: Key Country Dynamics
  • Fig. 64 India contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 65 India: Key Country Dynamics
  • Fig. 66 Australia contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 67 Australia: Key Country Dynamics
  • Fig. 68 South Korea contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea: Key Country Dynamics
  • Fig. 70 Thailand contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 71 Thailand: Key Country Dynamics
  • Fig. 72 Latin America contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil: Key Country Dynamics
  • Fig. 75 Argentina contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina: Key Country Dynamics
  • Fig. 77 Middle East and Africa contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa: Key Country Dynamics
  • Fig. 80 Saudi Arabia contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 81 Saudi Arabia: Key Country Dynamics
  • Fig. 82 UAE contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 83 UAE: Key Country Dynamics
  • Fig. 84 Kuwait contraceptive market, 2018 - 2030 (USD Million)
  • Fig. 85 Kuwait: Key Country Dynamics
  • Fig. 86 Company categorization
  • Fig. 87 Strategy mapping
  • Fig. 88 Company market position analysis
目次
Product Code: 978-1-68038-448-2

Contraceptive Market Growth & Trends:

The global contraceptive market size is anticipated to reach USD 44.04 billion by 2030 and is anticipated to grow at a CAGR of 5.92% during the forecast period, according to a new report by Grand View Research, Inc. The growing prevalence of Sexually Transmitted Infections (STIs), especially HIV, and the growing awareness of contraception in developing countries is expected to drive the industry growth during the forecast period. The presence of high unmet contraceptive needs coupled with the implementation of favorable government policies is expected to significantly contribute to market growth.

The government spending on contraceptives is growing rapidly. This is expected to drive the growth of the market over the forecast period. This investment typically supports initiatives such as subsidized or free contraceptive services, educational campaigns, and distribution programs. Such efforts increase accessibility to contraceptives and raise awareness about family planning and reproductive health, boosting the growth of the market. According to the Family Planning 2030 report, the U.S. donated the largest funding for family planning in 2022, accounting for around USD 582.9 million (43%), followed by the Netherlands (USD 217.4 million (16%)), UK (USD 174.7 million (13%)), Sweden (USD 121.3 million (9%)) and Canada (USD 88.3 million (7%)).

Due to the highly competitive nature of the market, major companies are focusing on significant investments in Research and Development (R&D) and adopting various strategies such as mergers and acquisitions and expanding their product pipelines. For instance, in December 2023, Quotient Sciences, a drug development company based in Nottingham, announced the initiation of the first trial for a hormone-free male birth control pill called YCT-529.

Contraceptive Market Report Highlights:

  • Based on product, the contraceptive device segment dominated the market with the largest revenue share in 2023. This is attributed to the higher success rates and the single-use nature of the devices.
  • Moreover, the contraceptive drugs segment is expected to witness the fastest CAGR during the forecast period owing to the easy accessibility, affordability, and significant success rates pertaining to these medications.
  • The North America region held the largest market share in 2023. This can be attributed to the high user awareness levels and easy product availability
  • In June 2023, DKT Healthcare Uganda launched a new condom variant called Kiss Extra Time designed to prolong sexual performance and enhance the intimate experience for couples. The condom is available for purchase at USD 0.16 in drug shops and pharmacies across Uganda, alongside other variants such as Kiss Passion Fruit, Kiss Strawberry, Kiss Classic, Kiss Chocolate, and Kiss Studded, all designed to cater to diverse preferences.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
    • 1.8.2. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Government and NGO initiatives to promote contraceptive methods
      • 3.2.1.2. Increasing prevalence of unwanted pregnancies and rising number of women with unmet contraceptive drugs and devices needs
      • 3.2.1.3. Increasing prevalence of sexually transmitted diseases (STDs)
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Rapidly aging population and rising prevalence of infertility
      • 3.2.2.2. Adverse effects associated with the use of contraceptive drugs and devices
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Contraceptive Drugs
    • 4.4.1. Contraceptive drugs market, 2018 - 2030 (USD Million)
    • 4.4.2. Contraceptive Pills
      • 4.4.2.1. Contraceptive pills market, 2018 - 2030 (USD Million)
    • 4.4.3. Patch
      • 4.4.3.1. Patch market, 2018 - 2030 (USD Million)
    • 4.4.4. Injectables
      • 4.4.4.1. Injectables market, 2018 - 2030 (USD Million)
  • 4.5. Contraceptive Devices
    • 4.5.1. Contraceptive devices market, 2018 - 2030 (USD Million)
    • 4.5.2. Condom
      • 4.5.2.1. Condom market, 2018 - 2030 (USD Million)
      • 4.5.2.2. Male Condom
      • 4.5.2.2.1.Male condom market, 2018 - 2030 (USD Million)
      • 4.5.2.3. Female Condom
      • 4.5.2.3.1.Female condom market, 2018 - 2030 (USD Million)
    • 4.5.3. Subdermal Implants
      • 4.5.3.1. Subdermal implants market, 2018 - 2030 (USD Million)
    • 4.5.4. Intra-Uterine Devices (IUDs)
      • 4.5.4.1. Intra-Uterine devices (IUDs) market, 2018 - 2030 (USD Million)
      • 4.5.4.2. Copper IUD
      • 4.5.4.2.1.Copper IUD market, 2018 - 2030 (USD Million)
      • 4.5.4.3. Hormonal IUD
      • 4.5.4.3.1.Hormonal IUD market, 2018 - 2030 (USD Million)
    • 4.5.5. Vaginal Ring
      • 4.5.5.1. Vaginal ring market, 2018 - 2030 (USD Million)
    • 4.5.6. Diaphragm
      • 4.5.6.1. Diaphragm market, 2018 - 2030 (USD Million)

Chapter 5. Regional Estimates & Trend Analysis by Application& Ownership

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key country dynamic
      • 5.4.2.2. Regulatory framework
      • 5.4.2.3. Competitive insights
      • 5.4.2.4. U.S. contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key country dynamic
      • 5.4.3.2. Regulatory framework
      • 5.4.3.3. Competitive insights
      • 5.4.3.4. Canada contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key country dynamic
      • 5.4.4.2. Regulatory framework
      • 5.4.4.3. Competitive insights
      • 5.4.4.4. Mexico contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key country dynamic
      • 5.5.2.2. Regulatory framework
      • 5.5.2.3. Competitive insights
      • 5.5.2.4. Germany contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. UK
      • 5.5.3.1. Key country dynamic
      • 5.5.3.2. Regulatory framework
      • 5.5.3.3. Competitive insights
      • 5.5.3.4. UK contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key country dynamic
      • 5.5.4.2. Regulatory framework
      • 5.5.4.3. Competitive insights
      • 5.5.4.4. France contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key country dynamic
      • 5.5.5.2. Regulatory framework
      • 5.5.5.3. Competitive insights
      • 5.5.5.4. Italy contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key country dynamic
      • 5.5.6.2. Regulatory framework
      • 5.5.6.3. Competitive insights
      • 5.5.6.4. Spain contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Denmark
      • 5.5.7.1. Key country dynamic
      • 5.5.7.2. Regulatory framework
      • 5.5.7.3. Competitive insights
      • 5.5.7.4. Denmark contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Sweden
      • 5.5.8.1. Key country dynamic
      • 5.5.8.2. Regulatory framework
      • 5.5.8.3. Competitive insights
      • 5.5.8.4. Sweden contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Norway
      • 5.5.9.1. Key country dynamic
      • 5.5.9.2. Regulatory framework
      • 5.5.9.3. Competitive insights
      • 5.5.9.4. Norway contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key country dynamic
      • 5.6.2.2. Regulatory framework
      • 5.6.2.3. Competitive insights
      • 5.6.2.4. Japan contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key country dynamic
      • 5.6.3.2. Regulatory framework
      • 5.6.3.3. Competitive insights
      • 5.6.3.4. China contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key country dynamic
      • 5.6.4.2. Regulatory framework
      • 5.6.4.3. Competitive insights
      • 5.6.4.4. India contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamic
      • 5.6.5.2. Regulatory framework
      • 5.6.5.3. Competitive insights
      • 5.6.5.4. South Korea contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Key country dynamic
      • 5.6.6.2. Regulatory framework
      • 5.6.6.3. Competitive insights
      • 5.6.6.4. Australia contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key country dynamic
      • 5.6.7.2. Regulatory framework
      • 5.6.7.3. Competitive insights
      • 5.6.7.4. Thailand contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key country dynamic
      • 5.7.2.2. Regulatory framework
      • 5.7.2.3. Competitive insights
      • 5.7.2.4. Brazil contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key country dynamic
      • 5.7.3.2. Regulatory framework
      • 5.7.3.3. Competitive insights
      • 5.7.3.4. Argentina contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key country dynamic
      • 5.8.2.2. Regulatory framework
      • 5.8.2.3. Competitive insights
      • 5.8.2.4. South Africa contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key country dynamic
      • 5.8.3.2. Regulatory framework
      • 5.8.3.3. Competitive insights
      • 5.8.3.4. Saudi Arabia contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key country dynamic
      • 5.8.4.2. Regulatory framework
      • 5.8.4.3. Competitive insights
      • 5.8.4.4. UAE contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key country dynamic
      • 5.8.5.2. Regulatory framework
      • 5.8.5.3. Competitive insights
      • 5.8.5.4. Kuwait contraceptive market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. AbbVie Inc.
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Bayer AG
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Organon Group of Companies
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. Pfizer Inc.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Afaxys, Inc.
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Viatris Inc.
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Agile Therapeutics
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Johnson & Johnson Services, Inc.
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. HELM AG
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Church & Dwight Co., Inc.
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Veru Inc.
      • 6.5.11.1. Overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. China Resources (Group) Co., LTD.
      • 6.5.12.1. Overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives